Baroreflex therapy for heart failure patients
Part of Heart & circulation clinical trials.
This trial tests a device that stimulates a nerve in your neck to help your heart pump better. It is for people with heart failure and a weak heart pump who still have symptoms despite taking medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with a weak pump (ejection fraction of 35% or less) – measured within the last year
- You currently have shortness of breath or fatigue with minimal activity (NYHA Class III) or you have symptoms with moderate activity (Class II) and had worse symptoms in the past (Class III)
- A blood test in the last 3 months shows a specific heart stress marker (NT-proBNP) is below 1600 pg/ml
- You are on the best tolerated heart failure medications and have any needed heart devices in place
- You are 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.
This trial tests a device called Barostim, which is implanted under the skin to stimulate nerves that help control heart failure. It's for people with mild to moderate heart failure whose symptoms are not fully controlled by medications.
This trial tests a new treatment that uses a device to calm overactive nerves in the lung's blood vessels. It is for heart failure patients who also have high blood pressure in their lungs, to see if it can help them breathe easier and feel better.
This trial tests a device that stimulates your diaphragm (the muscle that helps you breathe) while you have heart failure. It may help improve your breathing and heart function. The study is for people with moderate heart failure symptoms whose heart pumps less blood than normal.
This trial tests whether a minimally invasive procedure called renal denervation—which reduces nerve activity in blood vessels near the kidneys—can help people with heart failure feel better and exercise with less shortness of breath. You would receive this procedure in addition to your regular heart failure medications.
This trial tests a special pacemaker that uses nerve stimulation to help people with heart failure where the heart pumps normally but doesn't relax well. You would receive this device during a standard pacemaker procedure, and researchers would track how it affects your symptoms and quality of life.
Hear when a new HFrEF - Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.